Crescita Therapeutics Inc.
CRRTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 11.7% | -25.5% | 40.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 49.1% | 59.1% | 56% | 59.7% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -6.8% | -2.6% | 8.5% | 3.6% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -14% | -11.3% | 3.7% | -6.6% |
| EPS Diluted | -0.14 | -0.098 | 0.041 | -0.053 |
| % Growth | -42.9% | -338.4% | 177.3% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |